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As the central organ in drug metabolism and toxicity, liver failure often results in a fatal 
threat to human life, which raised up the demands for liver tissue construct of a clinically relevant 
size (for instance, about 500 cm
3
, which is the limited required volume of implantable liver with 
the cell density and functionalities being equal to those of the real tissue).  General 
introduction of liver and the clinical treatment, previous technologies as well as this thesis 
approach to engineer large implantable liver tissue equivalents is presented in Ch. 1.  Towards 
constructing an implantable liver tissue, both decellularization and artificial liver construction are 
promising approaches.  However, the former method requires organ to organ operations and the 
donor shortage and low cell density issues cannot be ignored.  On the contrary, the more practical 
artificial liver construction in vitro has recently been the focus of much attention in the field of 
bioengineering using “bottom up” route—cellular aggregate assembly, and “top down” route—
three-dimensional (3D) scaffold fabrication.  Whereas this approach still faces the unsolved 
problems of insufficient oxygenation in aggregate assembly and low resolution design of 
scaffolds.  Therefore, the two major issues in approaching to implantable liver tissue equivalents 
can be pointed out as: (1) improvement of mass transfer in the engineered liver tissues to achieve 
high per-volume-based functionality; (2) scaling up the engineered liver tissue to a clinically 
significant size.  My research goal is to establish the engineering methodology towards 
implantable liver tissue equivalent construction, by integration of both bottom-up and top-down 
technologies. This is a novel approach resolving mass transfer deficiencies simultaneous from 
micro and macro scales, meanwhile addressing the adequate cell number.  Specifically, the 
research purposes are divided into 3 parts as follows: 
(1) To improve the oxygenation and nutrient supply in cellular aggregate assembly by 
utilizing their interstitial gaps, which intends to solve the problems in local (within culture 
chamber) mass transfer; 
(2) To investigate on the cellular aggregate dimension with improved design; 
(3) To optimize the scaling up towards a clinically significant mass by fine designed 3D 
scaffold. 
 
Firstly, cellular aggregate assembly was improved by applying “spacing tissue elements” 
concept in Ch. 2, namely creating some spacing between the packed aggregates for securing 
better mass transfer by immobilizing them with biodegradable single poly-L-lactic acid (PLLA) 
fibers in small perfusion bioreactor.  To achieve this, a novel culture method whereby aggregates 
were constructed using a polydimethylsiloxane (PDMS)-based honeycomb microwell arrays.  
Primary rat hepatocyte aggregates around 100 μm in diameter coated with human umbilical vein 
endothelial cells (HUVECs) were spontaneously and quickly formed after 12 h of incubation.  
Then, recovered endothelialized rat hepatocyte aggregates were mixed with PLLA fibers in 
suspension, and packed into a PDMS-based bioreactor.  7 days of perfusion culture was 
successfully achieved with more than 73.8% cells retained in the bioreactor.  As expected, the 
fibers enhanced aggregate retention and functions, which were evidenced from the improved 
albumin production and more spherical morphology compared with fibre-free packing.  The 
results showed the advantages of using PDMS-based microwells to form heterotypic aggregates 
and also demonstrates the feasibility of spacing tissue elements for improving oxygen and 
nutrient supply to tissue engineering based on modular assembly.  
During the perfusion culture, I found the cellular aggregate disintegration gradually 
happen.  The broken aggregate parts may result in floating debris that hinders the perfusion to 
some areas.  Thus, to maintain the homogeneous flow with sufficient mass transfer, stable cellular 
modules with enough mechanical strength are necessary.  To circumvent this obstacle of cellular 
aggregate disintegration, I designed a module with a hollow structure in Ch. 3, and fabricated it 
using biodegradable polyglycolic acid (PGA).  The module was designed to be a cylinder with a 
hollow central canal 500 μm in diameter and an outer diameter varying from 1100 to 1300 μm.   
Hep G2 cells, which were considered as proliferative progenitors, were found to be well 
immobilized on the PGA module after collagen coating.  Given that 200 μm is the limitation of 
oxygen diffusion in vivo, PGA hollow modules were able to sufficiently secure good mass 
transfer to the cultured cells.  Hep G2 cells were found to maintain higher cell viability 
(suggested by calcein staining results) along with higher hepatic function (suggested by cellular 
albumin production and glucose consumption results) when cultured in the module with both the 
inner canal and transverse pores on the side wall.  As possessing the advantages of cell affinity, 
maintaining hepatic cell functions and stable in culture medium, PGA hollow modules with 
loaded cells are expected to replace pure cellular aggregates in the future for further scale up. 
To further produce a large liver tissue equivalent by scaling up the “spacing cellular 
aggregates” along with improved macro-circulation of medium for better oxygen and nutrient 
supply, a 3D scaffold was designed with flow channels homogeneously delivering medium to the 
whole construct in Ch. 4.  The scaffold was designed based on the real liver structure, which 
comprised 43 culture chambers assembled on three layers.  12 chambers are posited on the 1st 
and the 3rd layer, and 19 chambers on the 2nd layer, producing a construct with symmetrical 
outer shape. Then, the construct of 43 culture chambers was arranged again in the same way of 
pattern to finally achieve a structure 500 cm
3
 in volume.  Culture chambers were designed with a 
hexagonal section about 0.27 cm
3
 in volume.  Interconnected flow-channels were designed to 
deliver culture medium independently to each of the chambers.  The diameter of each flow 
channel was calculated based on Murray’s law and Hagen-Poiseuille’s equation to ensure the 
same pressure drop in the flow to each chamber.  The scaffold was fabricated using nylon-12 due 
to its high mechanical properties via selective laser sintering (SLS) technique by a collaborative 
lab. 
So far here, the insufficient mass transfer situation was intended to improve from both 
micro- (within culture chamber, local scale) and macro- (out of culture chamber, at higher 
hierarchical) scale.  In Ch. 5, to address another problem of clinically significant mass of the 
constructed liver tissue, the loosely packed aggregates were perfusion cultured in the designed 3D 
scaffold.  Endothelialized hepatic aggregates were obtained by co-culture of Hep G2 and TMNK-
1 cells, which are the immortalized human liver sinusoidal endothelial cells, using PDMS 
microwells 200 μm in diameter.  Formed aggregates were collected and mixed with a PLLA fiber 
suspension and inoculated to the scaffold.  After 10 days of perfusion, the results of increased 
albumin production, glucose consumption and high cell viability demonstrated that present 3D 
scaffold consisting of chambers for cell culture and independent flow channels for medium 
delivery was essential for proper cell growth and function.  The first attempt on approach to 
implantable liver tissue equivalent by integration of “bottom-up” and “top-down” concepts was 
proved successful according to above mentioned results.  With fully packing aggregates in the 
culture chamber and further scaling up the scaffold to second hierarchic, the present design and 
methodology are expected to finally realize an implantable liver of 500 cm
3
 with well reserved 
per-volume-based functionality.  
 
Finally, in Ch. 6, I present the conclusions and future outlook of the thesis.  This 
dissertation provides efficient methodologies arranging the implantable liver tissue equivalents 
simultaneously from micro and macro scale. The integrated approach provides the engineered 
liver tissue with improved mass transfer in bottom-up aspect, meanwhile the scalable feature of 
the scaffold design guarantee the possibility of approaching to a clinically relevant size with well 
revered per-volume-based functionalities in top-down aspect.  As expected, a liver tissue 
construct 11.63 cm
3
 in volume has been successfully engineered with better maintained cellular 
viability and hepatic function, suggesting the promising future of further developing the scalable 
scaffold towards a construct 500 cm
3
 sized in the future.  The developed methodology of 
integration of “bottom-up” and “top-down” concepts will contribute to tissue engineering 
promising approach to construction of implantable tissue organ equivalents. 
 
